StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$3.01−0.37 (-10.81%)

Close on Nov 17, 2026Market cap $58.22MP/E –Yield –

Corbus Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Corbus Pharmaceuticals's operating margin for the twelve months ending Mar 31, 2022 was -20990.2%. For fiscal 2021 it was -6350.1%, against -3119.2% the year before. The highest annual figure on record is -213.3% in fiscal 2019.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2021Dec 31, 2021-6350.1%−3230.9
FY2020Dec 31, 2020-3119.2%−2905.9
FY2019Dec 31, 2019-213.3%+963.5
FY2018Dec 31, 2018-1176.8%+157.7
FY2017Dec 31, 2017-1334.4%−288.9
FY2016Dec 31, 2016-1045.6%+319.9
FY2015Dec 31, 2015-1365.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2021Sep 30, 2021-14257.1%−11496.4
Q2 FY2021Jun 30, 2021-12230.0%+1089.1
Q1 FY2021Mar 31, 2021-2379.4%−683.3
Q4 FY2020Dec 31, 2020-3162.0%−2105.4
Q3 FY2020Sep 30, 2020-2760.7%−1791.6
Q2 FY2020Jun 30, 2020-13319.1%−13325.0
Q1 FY2020Mar 31, 2020-1696.0%−289.5
Q4 FY2019Dec 31, 2019-1056.5%−143.8
Q3 FY2019Sep 30, 2019-969.1%+396.6
Q2 FY2019Jun 30, 20195.9%+1457.7
Q1 FY2019Mar 31, 2019-1406.5%−158.2
Q4 FY2018Dec 31, 2018-912.7%−39.1
Q3 FY2018Sep 30, 2018-1365.7%+716.5
Q2 FY2018Jun 30, 2018-1451.9%−875.8
Q1 FY2018Mar 31, 2018-1248.4%+767.4
Q3 FY2017Sep 30, 2017-873.6%−155.3
Q2 FY2017Jun 30, 2017-2082.2%–
Q1 FY2017Mar 31, 2017-576.1%–
Q4 FY2016Dec 31, 2016-2015.7%–
Q3 FY2016Sep 30, 2016-718.3%–

More Corbus Pharmaceuticals figures

See a number that looks wrong?